Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Delayed-Release in Type 2 Diabetes (DREAM-T2D)
NCT04854512Phase 3Suspended
- Sponsor
- Anji Pharma
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Anji Pharma. Started May 2021; status: suspended.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04854512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854512.